PET/CT > Indications
Indications for PET imaging with FDG
- Breast cancer: staging of distant metastasis, restaging, and monitoring response to treatment (when a change in therapy is anticipated based on results)
- Cervical cancer: staging as adjunct to conventional imaging
- Colorectal cancer: diagnosis, staging, and restaging
- Esophageal cancer: diagnosis, staging, and restaging
- Head and neck cancer (non-thyroid, non-CNS): diagnosis, staging, and restaging
- Lymphoma: diagnosis, staging, and restaging
- Melanoma: diagnosis, staging, and restaging
- Non small cell lung cancer: diagnosis, staging, and restaging
- Solitary pulmonary nodules: characterization
- Follicular cell thyroid cancer: restaging of recurrent or residual disease previously treated by thyroidectomy and radioiodine ablation in the setting of serum thyroglobulin > 10 ng/ml and a negative I-131 whole body scan
- Myocardial viability: primary or initial diagnosis or following an inconclusive SPECT prior to revascularization
- Refractory seizures (brain): pre-surgical evaluation only